Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
Contemporary embolization strategies for active sac management during EVAR.
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage ...
The U.S. FDA has posted several class I recalls in recent days, including a removal of one model of the Medtronic Vascular’s ...
Medtronic's recall of embolization device has been classified most serious by the U.S. Food and Drug Administration (USFDA), ...
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's (MDT.N), opens new tab embolization device as "most serious", following reports of the ...
Prostate artery embolization (PAE) is a procedure that helps treat urinary symptoms of an enlarged prostate without a risk of sexual side effects. Generally, both Original Medicare (parts A and B ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果